Determination of the glycemic threshold for the regression or prevention of diabetic microangiopathies, and the insulin injection regimen to establish strict glycemic control in NIDDM

Jpn J Med. 1991 Nov-Dec;30(6):618-21. doi: 10.2169/internalmedicine1962.30.618.

Authors

R Kawamori¹, T Kamada

Affiliation

¹ First Department of Medicine, Osaka University Medical School.

PMID: 1798230
DOI: 10.2169/internalmedicine1962.30.618

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Blood Glucose / metabolism
Diabetes Mellitus, Type 2 / blood*
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy
Diabetic Angiopathies / blood
Diabetic Angiopathies / prevention & control*
Diabetic Angiopathies / therapy
Humans
Insulin / administration & dosage
Prospective Studies
Sulfonylurea Compounds / therapeutic use

Substances

Blood Glucose
Insulin
Sulfonylurea Compounds